DEVELOPMENT OF SPRAY-DRIED MUCOADESIVE VALSARTAN NASAL MICROPARTICLES: FORMULATION, OPTIMIZATION AND EVALUATION Authors: Tufail Dana , SUFIYAN AHMAD, MD. RAGEEB AND SHAIKH TANVIR
ABSTRACT
The purpose of this research was to formulate, characterize, the Valsartan Nasal Microparticles
encapsulated in dried Lipidium sativum mucilage based spray dried mucoadhesive microspheres
for treating hypertension. Factorial design has been employed for the assessment of influence of
three independent variables, inlet temperature, feed flow rate and drug–polymer ratio on
production yield, particle size, and in vitro drug diffusion. Microparticles were evaluated for
particle size, entrapment efficiency, swelling property, in vitro mucoadhesion, in vitro drug
diffusion and stability studies. The result of differential scanning thermogram of Valsartan
microparticles showed the peak at 109.76 °C and polymer at 263.47 °C. This DSC study further
confirmed that there was no drug-polymer interaction in microparticles. X-ray diffraction The
diffractogram of isolated polymer showed the characteristic sharp peak at 9.2°, 12.5°, 17° and
27.6° due to presence of particles in geometrical shape and it indicated the polymer is crystalline
in nature. From the SEM photographs, it was observed that microparticles were found to be 5 µm
in size and spherical in shape having smooth surface morphology. FT-IR analysis of optimized formulation showed that the polymer and process parameters do not alter the performance
characteristic of drug, thus revealing stability of the finalized formulation. The best fit model for
the drug release was found to be Zero Order Model as indicated by higher R2
value. This proved
that the formulated microparticles showed sustained release. The mechanism for drug release
was followed Korsmeyer-peppas model as indicated by higher R2
value. It predicts that the drug
release is polymer concentration dependent which follows zero order model and polymer having
swelling and eroding properties which follows Korsmeyer-peppas model.
Keywords: Valsartan Nasal Microparticles, differential scanning thermogram, SEM, FT-IR analysis
Publication date: 01/06/2022 https://ijbpas.com/pdf/2022/June/MS_IJBPAS_2022_6132.pdfDownload PDFhttps://doi.org/10.31032/IJBPAS/2022/11.6.6132